177 related articles for article (PubMed ID: 38555608)
1. [Changes in the synthesis of short-chain fatty acids under the influence of various factors in healthy people and patients with type 2 diabetes mellitus].
Demidova TY; Teplova AS
Vopr Pitan; 2024; 93(1):33-43. PubMed ID: 38555608
[TBL] [Abstract][Full Text] [Related]
2. Evaluation and comparison of short chain fatty acids composition in gut diseases.
Niccolai E; Baldi S; Ricci F; Russo E; Nannini G; Menicatti M; Poli G; Taddei A; Bartolucci G; Calabrò AS; Stingo FC; Amedei A
World J Gastroenterol; 2019 Sep; 25(36):5543-5558. PubMed ID: 31576099
[TBL] [Abstract][Full Text] [Related]
3. Fermented dietary fiber from soy sauce residue exerts antidiabetic effects through regulating the PI3K/AKT signaling pathway and gut microbiota-SCFAs-GPRs axis in type 2 diabetic mellitus mice.
Mo Z; Zhan M; Yang X; Xie P; Xiao J; Cao Y; Xiao H; Song M
Int J Biol Macromol; 2024 Jun; 270(Pt 2):132251. PubMed ID: 38729488
[TBL] [Abstract][Full Text] [Related]
4. Gut Microbiota and Short Chain Fatty Acids: Implications in Glucose Homeostasis.
Portincasa P; Bonfrate L; Vacca M; De Angelis M; Farella I; Lanza E; Khalil M; Wang DQ; Sperandio M; Di Ciaula A
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163038
[TBL] [Abstract][Full Text] [Related]
5. Association of short-chain fatty acids and the gut microbiome with type 2 diabetes: Evidence from the Henan Rural Cohort.
Yang T; Wu C; Li Y; Wang C; Mao Z; Huo W; Li J; Li Y; Xing W; Li L
Nutr Metab Cardiovasc Dis; 2024 Jul; 34(7):1619-1630. PubMed ID: 38653672
[TBL] [Abstract][Full Text] [Related]
6. [The study of the content of short-chain fatty acids in the intestine of people with lipid metabolism disorders].
Kim NV; Zotov VA; Alekseev VA; Sheveleva SA
Vopr Pitan; 2023; 92(2):18-25. PubMed ID: 37346016
[TBL] [Abstract][Full Text] [Related]
7. Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition: the METS-Microbiome study protocol.
Dugas LR; Lie L; Plange-Rhule J; Bedu-Addo K; Bovet P; Lambert EV; Forrester TE; Luke A; Gilbert JA; Layden BT
BMC Public Health; 2018 Aug; 18(1):978. PubMed ID: 30081857
[TBL] [Abstract][Full Text] [Related]
8. The change of gut microbiota-derived short-chain fatty acids in diabetic kidney disease.
Zhong C; Dai Z; Chai L; Wu L; Li J; Guo W; Zhang J; Zhang Q; Xue C; Lin H; Luo Q; Cai K
J Clin Lab Anal; 2021 Dec; 35(12):e24062. PubMed ID: 34689373
[TBL] [Abstract][Full Text] [Related]
9. Association of Intestinal Microbiota with Metabolic Markers and Dietary Habits in Patients with Type 2 Diabetes.
Yamaguchi Y; Adachi K; Sugiyama T; Shimozato A; Ebi M; Ogasawara N; Funaki Y; Goto C; Sasaki M; Kasugai K
Digestion; 2016; 94(2):66-72. PubMed ID: 27504897
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiota: A new target for T2DM prevention and treatment.
Liu L; Zhang J; Cheng Y; Zhu M; Xiao Z; Ruan G; Wei Y
Front Endocrinol (Lausanne); 2022; 13():958218. PubMed ID: 36034447
[TBL] [Abstract][Full Text] [Related]
11. Short-Chain Fatty Acids, Maternal Microbiota and Metabolism in Pregnancy.
Ziętek M; Celewicz Z; Szczuko M
Nutrients; 2021 Apr; 13(4):. PubMed ID: 33918804
[TBL] [Abstract][Full Text] [Related]
12. Short-chain fatty acids: microbial metabolites that alleviate stress-induced brain-gut axis alterations.
van de Wouw M; Boehme M; Lyte JM; Wiley N; Strain C; O'Sullivan O; Clarke G; Stanton C; Dinan TG; Cryan JF
J Physiol; 2018 Oct; 596(20):4923-4944. PubMed ID: 30066368
[TBL] [Abstract][Full Text] [Related]
13. The potential mechanism of Liu-Wei-Di-Huang Pills in treatment of type 2 diabetic mellitus: from gut microbiota to short-chain fatty acids metabolism.
Yi ZY; Chen L; Wang Y; He D; Zhao D; Zhang SH; Yu R; Huang JH
Acta Diabetol; 2022 Oct; 59(10):1295-1308. PubMed ID: 35857109
[TBL] [Abstract][Full Text] [Related]
14. Potential type 2 diabetes mellitus drug HMPA promotes short-chain fatty acid production by improving carbon catabolite repression effect of gut microbiota.
Liu H; Qin Y; Li K; Li M; Yang J; Tao H; Tang Y; Yang L; Chen S; Liu Y; Yang C; Gao W; Sun T
Br J Pharmacol; 2021 Feb; 178(4):946-963. PubMed ID: 33284460
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulatory potential of gut microbiome-derived short-chain fatty acids (SCFAs).
Ratajczak W; Rył A; Mizerski A; Walczakiewicz K; Sipak O; Laszczyńska M
Acta Biochim Pol; 2019 Mar; 66(1):1-12. PubMed ID: 30831575
[TBL] [Abstract][Full Text] [Related]
16. Regulating the gut microbiota and SCFAs in the faeces of T2DM rats should be one of antidiabetic mechanisms of mogrosides in the fruits of Siraitia grosvenorii.
Zhang Y; Peng Y; Zhao L; Zhou G; Li X
J Ethnopharmacol; 2021 Jun; 274():114033. PubMed ID: 33741440
[TBL] [Abstract][Full Text] [Related]
17. The human gut microbiota and glucose metabolism: a scoping review of key bacteria and the potential role of SCFAs.
Palmnäs-Bédard MSA; Costabile G; Vetrani C; Åberg S; Hjalmarsson Y; Dicksved J; Riccardi G; Landberg R
Am J Clin Nutr; 2022 Oct; 116(4):862-874. PubMed ID: 36026526
[TBL] [Abstract][Full Text] [Related]
18. The Effect of
Zhang C; Fang B; Zhang N; Zhang Q; Niu T; Zhao L; Sun E; Wang J; Xiao R; He J; Li S; Chen J; Guo J; Xiong W; Wang R
Nutrients; 2024 May; 16(11):. PubMed ID: 38892624
[TBL] [Abstract][Full Text] [Related]
19. Systemic availability and metabolism of colonic-derived short-chain fatty acids in healthy subjects: a stable isotope study.
Boets E; Gomand SV; Deroover L; Preston T; Vermeulen K; De Preter V; Hamer HM; Van den Mooter G; De Vuyst L; Courtin CM; Annaert P; Delcour JA; Verbeke KA
J Physiol; 2017 Jan; 595(2):541-555. PubMed ID: 27510655
[TBL] [Abstract][Full Text] [Related]
20. The Role of Dietary Fibre in Modulating Gut Microbiota Dysbiosis in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
Ojo O; Feng QQ; Ojo OO; Wang XH
Nutrients; 2020 Oct; 12(11):. PubMed ID: 33113929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
